발기부전 치료기기 시장 : 기기 유형별, 연령대별, 원인별, 최종 용도별 - 예측(2024-2032년)

Global Erectile Dysfunction Device Market will indicate over 9.3% CAGR between 2024 and 2032, driven by escalating efforts to destigmatize erectile dysfunction by advocacy groups and healthcare providers globally. By challenging societal taboos and promoting open dialogue, these initiatives empower men to seek necessary medical assistance without fear or shame. This cultural shift enhances individual health outcomes and fuels market growth for erectile dysfunction treatments.

For instance, in November 2023, MangoRx launched a charitable campaign focusing on mens health awareness. The company pledges to donate 50% of sales proceeds from its branded merchandise throughout the month to support various mens health and wellness charities.

As more men feel comfortable discussing their concerns and accessing healthcare services, demand rises for effective solutions, including medical devices and therapies. Ultimately, destigmatization efforts play a crucial role in expanding the market for erectile dysfunction treatments, enhancing overall patient care.

The overall erectile dysfunction device market is classified based on device type, age group, cause, end-use, and region.

The surgical devices segment will register an impressive CAGR from 2024 to 2032. Surgical devices, such as penile implants, offer a long-term solution for ED that may be preferred by patients who have not responded well to other treatments. Moreover, advancements in surgical techniques and device design have improved outcomes, reducing complications and recovery times. As awareness grows and the stigma surrounding ED diminishes, more men are exploring surgical options as a viable solution to restore sexual function. This trend is supported by healthcare providers seeking effective, durable treatment options for their patients.

The neurological disorders sector will seize a notable erectile dysfunction device market share by 2032 because of the prevalence of conditions such as multiple sclerosis MS and spinal cord injuries SCI that can lead to ED. These patients often require specialized treatments that can address both the neurological aspects affecting sexual function and the physical ability to achieve and maintain an erection. ED devices provide non-invasive or minimally invasive options that can be integrated into comprehensive treatment plans, offering these patients a chance to regain sexual function and improve their quality of life despite their underlying neurological conditions.

Europe erectile dysfunction device market will register significant growth, with a promising CAGR through 2032. Europe aging population, coupled with increasing awareness and acceptance of ED as a treatable condition, has fueled demand for effective solutions like ED devices. Innovations in healthcare infrastructure and reimbursement policies in many European countries have made these devices more accessible to a broader demographic. Cultural attitudes toward healthcare and quality of life also contribute, as more men seek out non-invasive treatments that can restore sexual function discreetly and effectively, bolstering market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of erectile dysfunction
    • 3.2.1.2 Technological advancement in devices
    • 3.2.1.3 Growing awareness and acceptance
    • 3.2.1.4 Rise in R&D investment
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Risk of complications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Reimbursement scenario
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Non-surgical devices
  • 5.2.1 Erectile dysfunction shock wave generators
  • 5.2.2 Vacuum constriction devices
  • 5.2.3 External penile rigidity devices
• 5.3 Surgical devices
  • 5.3.1 Penile implants
    • 5.3.1.1 Inflatable implants
    • 5.3.1.2 Malleable implants
  • 5.3.2 Other surgical devices

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Less than 40
• 6.3. 40-60 years
• 6.4 More than 60 years

Chapter 7 Market Estimates and Forecast, By Cause, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Diabetes
• 7.3 Neurological disorders
• 7.4 Hypertension
• 7.5 Other causes

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Clinics
• 8.4 Ambulatory surgical centers
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Augusta Medical Systems
• 10.2 Boston Scientific Corporation
• 10.3 Coloplast Corporation
• 10.4 Medispec Ltd.
• 10.5 MTS Medical UG
• 10.6 NOVAmedtek
• 10.7 Owen Mumford Ltd.
• 10.8 Promedon
• 10.9 SILIMED
• 10.10 STORZ MEDICAL AG
• 10.11 Zephyr Surgical Implants
• 10.12 Zimmer Aesthetics